KARL STORZ SE & CO. KG

Manufacturer adverse-event records for KARL STORZ SE & CO. KG come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2017–2026 · thin-book · elevated Death-code · balanced

Volume signature

KARL STORZ SE & CO. KG is a thinner MAUDE footprint

KARL STORZ SE & CO. KG accounts for 4,723 FDA MAUDE reports (#372 of 443, thin-book tercile). Death-coded event_type share is 0.89% (elevated); Injury share 32.6% (balanced).

What the volume reading shows for KARL STORZ SE & CO. KG

The standout signal for KARL STORZ SE & CO. KG is filing volume: 4,723 adverse-event reports in FDA MAUDE (#372 of 443, thin-book). Death-coded event_type share sits at 0.89% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 3,140 (66.5% of event_type total). Peak single-year volume reaches 2,392 reports across 10 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,723
Total Reports
42
Event-type Death
1,538
Injury Reports
20
Device Types

Event Types

Malfunction 3,140 (66.5%)
Injury 1,538 (32.6%)
Death 42 (0.9%)
Other 3 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,663 (55.0%)
Other 1,322 (27.3%)
Required Intervention 526 (10.9%)
O 69 (1.4%)
R 58 (1.2%)
Hospitalization 58 (1.2%)
Death 40 (0.8%)
H 36 (0.7%)
Disability 23 (0.5%)
Life Threatening 21 (0.4%)
D 9 (0.2%)
S 8 (0.2%)
Congenital Anomaly 6 (0.1%)
L 4 (0.1%)
C 2 (0.0%)

Yearly Trend

17
2017: 6
18
2018: 49
19
2019: 103
20
2020: 143
21
2021: 78
22
2022: 197
23
2023: 742
24
2024: 662
25
2025: 2,392
26
2026: 351